These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37072535)

  • 1. Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study.
    Jaworska N; Krewulak KD; Schalm E; Niven DJ; Ismail Z; Burry LD; Leigh JP; Fiest KM
    J Gen Intern Med; 2023 Aug; 38(10):2262-2271. PubMed ID: 37072535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A National Modified Delphi Consensus Process to Prioritize Experiences and Interventions for Antipsychotic Medication Deprescribing Among Adult Patients With Critical Illness.
    Jaworska N; Makuk K; Krewulak KD; Niven DJ; Ismail Z; Burry LD; Mehta S; Fiest KM
    Crit Care Explor; 2022 Dec; 4(12):e0806. PubMed ID: 36506828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A scoping review of perceptions from healthcare professionals on antipsychotic prescribing practices in acute care settings.
    Jaworska N; Moss SJ; Krewulak KD; Stelfox Z; Niven DJ; Ismail Z; Burry LD; Fiest KM
    BMC Health Serv Res; 2022 Oct; 22(1):1272. PubMed ID: 36271347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
    Evrard P; Pétein C; Beuscart JB; Spinewine A
    Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic prescribing practices and patient, family member and healthcare professional perceptions of antipsychotic prescribing in acute care settings: a scoping review protocol.
    Jaworska N; Moss SJ; Krewulak KD; Stelfox Z; Niven D; Ismail Z; Burry L; Fiest K
    BMJ Open; 2022 Jun; 12(6):e057585. PubMed ID: 35768120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the behavior change wheel to link published deprescribing strategies to identified local primary healthcare needs.
    Bai I; Isenor JE; Reeve E; Whelan AM; Martin-Misener R; Burgess S; Kennie-Kaulbach N
    Res Social Adm Pharm; 2022 Aug; 18(8):3350-3357. PubMed ID: 34895842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare professionals' perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework.
    Alwidyan T; McCorry NK; Parsons C
    Int J Pharm Pract; 2023 May; 31(3):305-313. PubMed ID: 36866441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists.
    Scott S; Twigg MJ; Clark A; Farrow C; May H; Patel M; Taylor J; Wright DJ; Bhattacharya D
    Age Ageing; 2019 Dec; 49(1):102-110. PubMed ID: 31711097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and opportunities in creating a deprescribing program in the emergency department: A qualitative study.
    Lee S; Bobb Swanson M; Fillman A; Carnahan RM; Seaman AT; Reisinger HS
    J Am Geriatr Soc; 2023 Jan; 71(1):62-76. PubMed ID: 36258309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups.
    Evrard P; Damiaens A; Patey AM; Grimshaw JM; Spinewine A
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100258. PubMed ID: 37124470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing central nervous system medication deprescribing and behavior change in hospitalized older adults.
    Pavon JM; Zhang AD; Fish LJ; Falkovic M; Colón-Emeric CS; Gallagher DM; Schmader KE; Hastings SN
    J Am Geriatr Soc; 2024 Aug; 72(8):2359-2371. PubMed ID: 38826146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
    Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
    Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Starting to think that way from the start": approaching deprescribing decision-making for people accessing palliative care - a qualitative exploration of healthcare professionals views.
    Robinson-Barella A; Richardson CL; Bayley Z; Husband A; Bojke A; Bojke R; Exley C; Hanratty B; Elverson J; Jansen J; Todd A
    BMC Palliat Care; 2024 Sep; 23(1):221. PubMed ID: 39242514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the prescribing behaviour of independent prescriber optometrists: a qualitative study using the Theoretical Domains Framework.
    Spillane D; Courtenay M; Chater A; Family H; Whitaker A; Acton JH
    Ophthalmic Physiol Opt; 2021 Mar; 41(2):301-315. PubMed ID: 33608897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing deprescribing in primary care for those towards the end of life: A qualitative interview study with patients and healthcare practitioners.
    van der Waal MS; Teunissen SC; Uyttewaal AG; Verboeket-Crul C; Smits-Pelser H; Geijteman EC; Grant MP
    Palliat Med; 2024 Sep; 38(8):884-892. PubMed ID: 38916262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    PLoS One; 2016; 11(4):e0151066. PubMed ID: 27093289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.